<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml</title><link>https://www.medscape.com/cx/rssfeeds/2700.xml</link><description>Individual feed output.</description><lastBuildDate>Fri, 24 Oct 2025 22:55:34 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Immune Checkpoint Add-Ons to BCG: No Slam Dunk</title><link>https://www.medscape.com/viewarticle/immune-checkpoint-add-ons-bcg-no-slam-dunk-2025a1000t36?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>BCG failure is much less common than previously thought in non-muscle invasive bladder cancer, so is adding a checkpoint inhibitor worth it? Medscape ...</description><pubDate>Fri, 24 Oct 2025 21:45:38 GMT</pubDate></item><item><title>Sex Differences Shape Chronic Rhinosinusitis Patterns</title><link>https://www.medscape.com/viewarticle/does-biological-sex-influence-chronic-rhinosinusitis-2025a1000t32?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Both age for women and sex are related to the likelihood of having chronic rhinosinusitis with polyps. Medscape Medical News</description><pubDate>Fri, 24 Oct 2025 21:16:54 GMT</pubDate></item><item><title>Both High and Low Temperatures Tied to Death Risk in HF</title><link>https://www.medscape.com/viewarticle/both-high-and-low-temperatures-tied-death-risk-hf-2025a1000t2o?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>Short-term exposure to low or high temperatures is linked to an increased likelihood of all-cause and cardiovascular disease death in patients with he...</description><pubDate>Fri, 24 Oct 2025 18:29:11 GMT</pubDate></item><item><title>Blenrep Returns: ADC Combo Approved for R/R MM</title><link>https://www.medscape.com/viewarticle/blenrep-returns-adc-combo-approved-r-r-mm-2025a1000t27?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png</image_url><description>Belantamab mafodotin remains in development, with its maker, GlaxoSmithKline, aiming for an upfront MM indication. Medscape Medical News</description><pubDate>Fri, 24 Oct 2025 17:01:32 GMT</pubDate></item><item><title>Adding Vaccine to Pembro Did Not Improve PFS in Melanoma</title><link>https://www.medscape.com/viewarticle/adding-vaccine-pembro-did-not-improve-pfs-melanoma-2025a1000t1q?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>Patients with untreated advanced melanoma do not appear to gain a survival advantage from the addition of a cancer vaccine to pembrolizumab, suggests ...</description><pubDate>Fri, 24 Oct 2025 15:25:07 GMT</pubDate></item></channel></rss>